3,662 research outputs found
Reviewing toxicokinetics with a focus on metabolism of new psychoactive substances in the zebrafish (larvae) model
Zebrafish (Danio rerio) share around 70% of their genome with humans and many
important enzymes for drug metabolism such as some cytochrome p450s
have direct orthologs in zebrafish. To date, several studies showed a similar
metabolism to humans in general. Furthermore, although using adult fish as
model organism requires approval by an Ethics Committee, using larvae until
120 h postfertilization does not necessarily need any approval at least in the
European Union. All these aspects seem to be beneficial for using zebrafish (larvae) in toxicokinetic studies for the so-called new psychoactive substances. These
compounds are expected to have similar effects as traditional drugs of abuse but
are often not listed as controlled drugs when they first appear on the market.
However, no information about their toxicokinetics is available when they appear,
which is particularly critical concerning their biotransformation. This knowledge
is important for example, for developing urine-based screening procedures or for
predicting drug–drug interactions. This focus article aims to briefly introduce into
the topic of using zebrafish (larvae) in the context of toxicokinetic studies, particularly metabolism studies, and will highlight some aspects such as the route of
administration, which are important to consider when using this model.
This article is categorized under:
Toxicology > New Psychoactive Substances
Toxicology > Analytica
Impact of the used solvent on the reconstitution efficiency of evaporated biosamples for untargeted metabolomics studies
Introduction
Untargeted metabolomics intends to objectively analyze a wide variety of compounds. Their diverse physicochemical properties make it difficult to choose an appropriate reconstitution solvent after sample evaporation without influencing the chromatography or hamper column sorbent integrity.
Objectives
The study aimed to identify the most appropriate reconstitution solvent for blood plasma samples in terms of feature recovery, four endogenous compounds, and one selected internal standard.
Methods
We investigated several reconstitution solvent mixtures containing acetonitrile and methanol to resolve human plasma extract and evaluated them concerning the peak areas of tryptophan-d5, glucose, creatinine, palmitic acid, and the phophatidylcholine PC(P-16:0/P-16:0), as well as the total feature count
Results
Results indicated that acetonitrile containing 30% methanol was best suited to match all tested criteria at least for human blood plasma samples.
Conclusion
Despite identifying the mixture of acetonitrile and methanol being suitable as solvent for human blood plasma extracts, we recommend to systematically test for an appropriate reconstitution solvent for each analyzed biomatrix
Searching for young Jupiter analogs around AP Col: L-band high-contrast imaging of the closest pre-main sequence star
The nearby M-dwarf AP Col was recently identified by Riedel et al. 2011 as a
pre-main sequence star (age 12 - 50 Myr) situated only 8.4 pc from the Sun. The
combination of its youth, distance, and intrinsically low luminosity make it an
ideal target to search for extrasolar planets using direct imaging. We report
deep adaptive optics observations of AP Col taken with VLT/NACO and Keck/NIRC2
in the L-band. Using aggressive speckle suppression and background subtraction
techniques, we are able to rule out companions with mass m >= 0.5 - 1M_Jup for
projected separations a>4.5 AU, and m >= 2 M_Jup for projected separations as
small as 3 AU, assuming an age of 40 Myr using the COND theoretical
evolutionary models. Using a different set of models the mass limits increase
by a factor of ~2. The observations presented here are the deepest
mass-sensitivity limits yet achieved within 20 AU on a star with direct
imaging. While Doppler radial velocity surveys have shown that Jovian bodies
with close-in orbits are rare around M-dwarfs, gravitational microlensing
studies predict that ~17% of these stars host massive planets with orbital
separations of 1-10 AU. Sensitive high-contrast imaging observations, like
those presented here, will help to validate results from complementary
detection techniques by determining the frequency of gas giant planets on wide
orbits around M-dwarfs.Comment: Accepted for publication in ApJ, 6 pages text ApJ style (incl.
references), 4 figures, 1 tabl
Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine dose
Amphetamine is widely consumed as drug of abuse due to its stimulating and cognitive enhancing effects. Since amphetamine has been on the market for quite a long time and it is one of the most commonly used stimulants worldwide, to date there is still limited information on its effects on the metabolome. In recent years, untargeted toxicometabolomics have been increasingly used to study toxicity-related pathways of such drugs of abuse to find and identify important endogenous and exogenous biomarkers. In this study, the acute effects of amphetamine intake on plasma and urinary metabolome in rats were investigated. For this purpose, samples of male Wistar rats after a single dose of amphetamine (5 mg/kg) were compared to a control group using an untargeted metabolomics approach. Analysis was performed using normal and reversed phase liquid chromatography coupled to high-resolution mass spectrometry using positive and negative ionization mode. Statistical evaluation was performed using Welch’s two-sample t test, hierarchical clustering, as well as principal component analysis. The results of this study demonstrate a downregulation of amino acids in plasma samples after amphetamine exposure. Furthermore, four new potential biomarkers N-acetylamphetamine, N-acetyl-4-hydroxyamphetamine, N-acetyl-4-hydroxyamphetamine glucuronide, and amphetamine succinate were identified in urine. The present study complements previous data and shows that several studies are necessary to elucidate altered metabolic pathways associated with acute amphetamine exposure
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography-high-resolution tandem mass spectrometry
The active, poisonous constituents in Taxus baccata, the yew plants, are taxine alkaloids whose main action is suggested to be a block of calcium and sodium channels.
The main alkaloids are taxine B (30%) and taxine A (1.3%). Symptoms can include bradycardia, bradypnea, diastolic, and cardiac standstill. The current investigation reports
the analytical toxicology of human blood and urine to confirm a suspected ingestion
of yew needles. This includes the qualitative detection of several yew ingredients,
including the main alkaloids, the validated quantification of 3,5-dimethoxyphenol,
and the discussion of suitable analytical targets. After analyzing human specimens
and yew needle extracts using the developed procedures, the five alkaloids
1-deotaxine B, taxicatin, taxine A, taxine B, and taxine I could be detected and tentatively identified. Finally, taxine A and B can be recommended as analytical targets
besides 3,5-dimethoxyphenol
Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug–drug interactions of drugs of abuse
Transporter-mediated drug–drug interactions (DDI) may induce adverse clinical events. As drugs of abuse (DOA) are marketed without preclinical safety studies, only very limited information about interplay with membrane transporters are available. Therefore, 13 DOA of various classes were tested for their in vitro affinity to the human breast cancer resistance protein (hBCRP), an important efflux transporter. As adenosine 5′-triphosphate (ATP) hydrolysis is crucial for hBCRP activity, adenosine 5′-diphosphate (ADP) formation was measured and used as in vitro marker for hBCRP ATPase activity. ADP quantification was performed by hydrophilic interaction liquid chromatography coupled to high-resolution tandem mass spectrometry and its amount in test compound incubations was compared to that in reference incubations using the hBCRP substrate sulfasalazine or the hBCRP inhibitor orthovanadate. If DOA caused stimulation or inhibition, further investigations such as Michaelis–Menten kinetic modeling or IC50 value determination were conducted. Among the tested DOA, seven compounds showed statistically significant hBCRP ATPase stimulation. The entactogen 3,4-BDB and the plant alkaloid mitragynine were identified as strongest stimulators. Their affinity to the hBCRP ATPase was lower than that of sulfasalazine but comparable to that of rosuvastatin, another hBCRP model substrate. Five DOA showed statistically significant hBCRP ATPase inhibition. Determination of IC50 values identified the synthetic cannabinoid receptor agonists JWH-200 and WIN 55,212-2 as the strongest inhibitors comparable to orthovanadate. The present study clearly demonstrated that tested DOA show in part high affinities to the hBCRP within the range of model substrates or inhibitors. Thus, there is a risk of hBCRP-mediated DDI, which needs to be considered in clinical settings
Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometry
Colchicum autumnale, which can be mistaken for Allium ursinum, contains the alkaloid
colchicine potentially leading to life-threatening up to fatal intoxications. We report
two cases of acute intoxications with unexplained circumstances. Using the authors'
systematic screening approaches, colchicine could be detected in blood plasma and
urine samples using liquid chromatography coupled to linear ion trap mass spectrometry (LC-ITMSn
) and high-resolution tandem mass spectrometry (LC-HRMS/MS).
Metabolites of colchicine could be identified in urine for confirmation of screening
results. Gas chromatography–mass spectrometry (GC-MS) analysis was also conducted, but colchicine could not be detected. Furthermore, colchicine concentration
was estimated via LC-HRMS/MS in plasma samples. Results of the systematic
screening indicated the ingestion of colchicine from both subjects. In both cases, the
parent compound was detected in blood plasma and urine using the LC-HRMS/MS
and LC-ITMSn system. An O-demethylation metabolite was identified in urine
samples of both subjects using LC-HRMS/MS; the N-deacetylation product was also
found in urine samples of both cases via LC-HRMS/MS and LC-ITMSn
. The use of
LC-ITMSn resulted only in the detection of the O-demethylation product in case
2. Plasma concentrations were estimated at 2.5 ng/ml and 4.7 ng/ml for cases 1 and
2, respectively. We demonstrated the detection of this highly toxic alkaloid in blood
plasma and urine using a time-saving and reliable clinical systematic screening.
Furthermore, we identified metabolites of colchicine being rarely discussed in
literature, which can be used as additional screening targets
What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?
Little is known about the role of flavin-containing monooxygenases (FMOs) in the metabolism of xenobiotics. FMO3 is the isoform in adult human liver with the highest impact on drug metabolism. The aim of the presented study was to elucidate the contribution of human FMO3 to the N-oxygenation of selected therapeutic drugs and drugs of abuse (DOAs). Its contribution to the in vivo hepatic net clearance of the N-oxygenation products was calculated by application of an extended relative activity factor (RAF) approach to differentiate from contribution of cytochrome P450 (CYP) isoforms. FMO3 and CYP substrates were identified using pooled human liver microsomes after heat inactivation and chemical inhibition, or single enzyme incubations. Kinetic parameters were subsequently determined using recombinant human enzymes and mass spectrometric analysis via authentic reference standards or simple peak areas of the products divided by those of the internal standard. FMO3 was identified as enzyme mainly responsible for the formation of N,N-diallyltryptamine N-oxide and methamphetamine hydroxylamine (>80% contribution for both). A contribution of 50 and 30% was calculated for the formation of N,N-dimethyltryptamine N-oxide and methoxypiperamide N-oxide, respectively. However, FMO3 contributed with less than 5% to the formation of 3-bromomethcathinone hydroxylamine, amitriptyline N-oxide, and clozapine N-oxide. There was no significant difference in the contributions when using calibrations with reference metabolite standards or peak area ratio calculations. The successful application of a modified RAF approach including FMO3 proved the importance of FMO3 in the N-oxygenation of DOAs in human metabolism
An easy and fast adenosine 5'-diphosphate quantification procedure based on hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry for determination of the in vitro adenosine 5'-triphosphatase activity of the human breast cancer resistance protein ABCG2
Interactions with the human breast cancer resistance protein (hBCRP) significantly influence the pharmacokinetic properties of a drug and can even lead to drug-drug interactions. As efflux pump from the ABC superfamily, hBCRP utilized energy gained by adenosine 5′-triphosphate (ATP) hydrolysis for the transmembrane movement of its substrates, while adenosine 5′-diphosphate (ADP) and inorganic phosphate were released. The ADP liberation can be used to detect interactions with the hBCRP ATPase. An ADP quantification method based on hydrophilic interaction liquid chromatography (HILIC) coupled to high resolution tandem mass spectrometry (HR-MS/MS) was developed and successfully validated in accordance to the criteria of the guideline on bioanalytical method validation by the European Medicines Agency. ATP and adenosine 5′-monophosphate were qualitatively included to prevent interferences. Furthermore, a setup consisting of six sample sets was evolved that allowed detection of hBCRP substrate or inhibitor properties of the test compound. The hBCRP substrate sulfasalazine and the hBCRP inhibitor orthovanadate were used as controls. To prove the applicability of the procedure, the effect of amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir on the hBCRP ATPase activity was tested. Nelfinavir, ritonavir, and saquinavir were identified as hBCRP ATPase inhibitors and none of the five HIV protease inhibitors turned out to be an hBCRP substrate. These findings were in line with a pervious publication
- …